MARATTO

article · BMC Infectious Diseases

Hepatitis B surface antigen seroprevalence in Morocco (2000–2024): a systematic review and meta-analysis

2025Open accessMohammed V University

Abstract

The pooled prevalence observed across included studies reinforces the hypothesis that Morocco is transitioning towards a low-endemic HBV status, which reflects the comprehensive national measures, along with the positive impact of systematic vaccination of newborn introduced in 1999 and certain groups as well. However, additional efforts remain necessary to sustain this progress and adequately address the weaknesses observed at the national level in managing HBV infection, particularly among certain at-risk groups.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12879-025-12002-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.